Øystein L. Holla

1.7k total citations
38 papers, 1.0k citations indexed

About

Øystein L. Holla is a scholar working on Surgery, Molecular Biology and Cell Biology. According to data from OpenAlex, Øystein L. Holla has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 14 papers in Molecular Biology and 8 papers in Cell Biology. Recurrent topics in Øystein L. Holla's work include Lipoproteins and Cardiovascular Health (15 papers), Cellular transport and secretion (5 papers) and Signaling Pathways in Disease (4 papers). Øystein L. Holla is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Cellular transport and secretion (5 papers) and Signaling Pathways in Disease (4 papers). Øystein L. Holla collaborates with scholars based in Norway, United States and Sweden. Øystein L. Holla's co-authors include Trond P. Leren, Knut Erik Berge, Jamie Cameron, Trine Ranheim, Mari Ann Kulseth, Kristian Tveten, Jon K. Laerdahl, Thea Bismo Strøm, Øyvind L. Busk and Jens Kristoffer Hertel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Human Molecular Genetics.

In The Last Decade

Øystein L. Holla

37 papers receiving 1.0k citations

Peers

Countries citing papers authored by Øystein L. Holla

Since Specialization

Citations

This map shows the geographic impact of Øystein L. Holla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øystein L. Holla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øystein L. Holla more than expected).

Fields of papers citing papers by Øystein L. Holla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øystein L. Holla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øystein L. Holla. The network helps show where Øystein L. Holla may publish in the future.

Co-authorship network of co-authors of Øystein L. Holla

This figure shows the co-authorship network connecting the top 25 collaborators of Øystein L. Holla. A scholar is included among the top collaborators of Øystein L. Holla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Øystein L. Holla. Øystein L. Holla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A monoallelic UXS1 variant associated with short‐limbed short stature 2024 ·Molecular Genetics & Genomic Medicine ·Cecilie F. Rustad, Paul Hoff Backe, Chunsheng Jin, Else Merckoll, Kristian Tveten, (unknown), Niclas G. Karlsson, Trine Prescott, (unknown), Berit Woldseth, Katja Benedikte Prestø Elgstøen, Øystein L. Holla	0
2	Moderately Prolonged QTc in Computer-Assessed ECG, Random Variation or Significant Risk Factor? A Literature Review 2022 ·SHILAP Revista de lepidopterología ·(unknown), Charlotte Gibbs, Øystein L. Holla, (unknown), Kristina H. Haugaa	2
3	Biallelic ANGPT2 loss-of-function causes severe early-onset non-immune hydrops fetalis 2021 ·Journal of Medical Genetics ·Marie Falkenberg Smeland, Pascal Brouillard, Trine Prescott, Laurence M. Boon, (unknown), (unknown), (unknown), Øystein L. Holla, Miikka Vikkula	5
4	A Nationwide Study of GATA2 Deficiency in Norway—the Majority of Patients Have Undergone Allo-HSCT 2021 ·Journal of Clinical Immunology ·Silje F. Jørgensen, Jochen Buechner, Anders Eivind Myhre, Eivind Galteland, Signe Spetalen, Mari Ann Kulseth, Hanne Sørmo Sorte, Øystein L. Holla, (unknown), (unknown), (unknown), Trond Flægstad, Yngvar Fløisand, (unknown), Børre Fevang, Pål Aukrust, Asbjørg Stray‐Pedersen, Tobias Gedde‐Dahl, Ingvild Nordøy	10
5	Influence of Obesity on Work Ability, Respiratory Symptoms, and Lung Function in Adults with Asthma 2019 ·Respiration ·(unknown), Martin Veel Svendsen, Jens Kristoffer Hertel, Øystein L. Holla, Paul K. Henneberger, Johny Kongerud, Anne Kristin Møller Fell	18
6	Next-generation sequencing of the monogenic obesity genes LEP , LEPR , MC4R , PCSK1 and POMC in a Norwegian cohort of patients with morbid obesity and normal weight controls 2017 ·Molecular Genetics and Metabolism ·Gry B. N. Nordang, Øyvind L. Busk, Kristian Tveten, Hans Ivar Hanevik, Anne Kristin Møller Fell, Jøran Hjelmesæth, Øystein L. Holla, Jens Kristoffer Hertel	49
7	Arvelige perifere nevropatier diagnostisert ved dypsekvensering 2015 ·Tidsskrift for Den norske legeforening ·Helle Høyer, Øyvind L. Busk, Øystein L. Holla, Linda M. Strand, Michael Bjørn Russell, Camilla Furu Skjelbred, Geir J. Braathen	6
8	Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulum 2011 ·Biochemical and Biophysical Research Communications ·Thea Bismo Strøm, Kristian Tveten, Øystein L. Holla, Jamie Cameron, Knut Erik Berge, Trond P. Leren	6
9	Characterization of a naturally occurring degradation product of the LDL receptor 2011 ·Molecular Genetics and Metabolism ·Kristian Tveten, Thea Bismo Strøm, Jamie Cameron, Øystein L. Holla, Knut Erik Berge, Trond P. Leren	16
10	Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors 2011 ·Journal of Lipid Research ·Øystein L. Holla, Jamie Cameron, Kristian Tveten, (unknown), Knut Erik Berge, Jon K. Laerdahl, Trond P. Leren	55
11	Removal of acidic residues of the prodomain of PCSK9 increases its activity towards the LDL receptor 2011 ·Biochemical and Biophysical Research Communications ·Øystein L. Holla, Jon K. Laerdahl, Thea Bismo Strøm, Kristian Tveten, Jamie Cameron, Knut Erik Berge, Trond P. Leren	24
12	Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domain 2010 ·Molecular Genetics and Metabolism ·Thea Bismo Strøm, Øystein L. Holla, Kristian Tveten, Jamie Cameron, Knut Erik Berge, Trond P. Leren	31
13	Splice-site mutation c.313+1, G>A in intron 3 of the LDL receptor gene results in transcripts with skipping of exon 3 and inclusion of intron 3 2009 ·Clinica Chimica Acta ·Jamie Cameron, Øystein L. Holla, Mari Ann Kulseth, Trond P. Leren, Knut Erik Berge	9
14	Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses 2009 ·Molecular Genetics and Metabolism ·Øystein L. Holla, Sigve Nakken, Morten Mattingsdal, Trine Ranheim, Knut Erik Berge, Joep C. Defesche, Trond P. Leren	36
15	A chimeric LDL receptor containing the cytoplasmic domain of the transferrin receptor is degraded by PCSK9 2009 ·Molecular Genetics and Metabolism ·Øystein L. Holla, Thea Bismo Strøm, Jamie Cameron, Knut Erik Berge, Trond P. Leren	25
16	Genome‐wide expression analysis of cells expressing gain of function mutant D374Y‐PCSK9 2008 ·Journal of Cellular Physiology ·Trine Ranheim, Morten Mattingsdal, Jessica M. Lindvall, Øystein L. Holla, Knut Erik Berge, Mari Ann Kulseth, Trond P. Leren	31
17	Mutation S462P in the PCSK9 gene reduces secretion of mutant PCSK9 without affecting the autocatalytic cleavage 2008 ·Atherosclerosis ·Jamie Cameron, Øystein L. Holla, Jon K. Laerdahl, Mari Ann Kulseth, Knut Erik Berge, Trond P. Leren	23
18	Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly 2007 ·BMC Cell Biology ·Øystein L. Holla, Jamie Cameron, Knut Erik Berge, Trine Ranheim, Trond P. Leren	56
19	4‐Phenylbutyrate restores the functionality of a misfolded mutant low‐density lipoprotein receptor 2007 ·FEBS Journal ·Kristian Tveten, Øystein L. Holla, Trine Ranheim, Knut Erik Berge, Trond P. Leren, Mari Ann Kulseth	48
20	Effect of mutations in the PCSK9 gene on the cell surface LDL receptors 2006 ·Human Molecular Genetics ·Jamie Cameron, Øystein L. Holla, Trine Ranheim, Mari Ann Kulseth, Knut Erik Berge, Trond P. Leren	220

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact